Natixis Advisors LLC bought a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 30,445 shares of the company’s stock, valued at approximately $2,021,000.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Securian Asset Management Inc. bought a new position in Ryan Specialty during the second quarter valued at about $474,000. Xponance Inc. boosted its position in shares of Ryan Specialty by 67.2% during the 2nd quarter. Xponance Inc. now owns 20,686 shares of the company’s stock valued at $1,198,000 after purchasing an additional 8,312 shares in the last quarter. Geneva Partners LLC bought a new position in shares of Ryan Specialty during the 3rd quarter valued at about $2,537,000. Susquehanna Fundamental Investments LLC raised its holdings in shares of Ryan Specialty by 2,354.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 100,614 shares of the company’s stock worth $5,827,000 after purchasing an additional 96,514 shares in the last quarter. Finally, Retirement Systems of Alabama acquired a new stake in Ryan Specialty during the second quarter valued at approximately $7,316,000. 84.82% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts have issued reports on the company. JPMorgan Chase & Co. upped their price target on Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. Barclays boosted their target price on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. The Goldman Sachs Group increased their price target on Ryan Specialty from $64.00 to $72.00 and gave the company a “neutral” rating in a research report on Wednesday, October 9th. Bank of America boosted their price objective on Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. Finally, UBS Group raised their target price on shares of Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a report on Tuesday, August 13th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $71.67.
Ryan Specialty Stock Performance
Shares of RYAN opened at $74.59 on Tuesday. The company has a market capitalization of $19.53 billion, a PE ratio of 96.87, a PEG ratio of 1.67 and a beta of 0.62. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company’s 50 day moving average price is $69.27 and its 200 day moving average price is $62.80. Ryan Specialty Holdings, Inc. has a 52 week low of $41.49 and a 52 week high of $75.39.
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The business had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. During the same period in the previous year, the company earned $0.32 EPS. The firm’s revenue was up 20.5% on a year-over-year basis. Research analysts expect that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current fiscal year.
Ryan Specialty Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be paid a dividend of $0.11 per share. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.59%. Ryan Specialty’s dividend payout ratio (DPR) is 57.14%.
Insider Activity
In other news, Director Nicholas Dominic Cortezi sold 5,375 shares of Ryan Specialty stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $64.73, for a total value of $347,923.75. Following the transaction, the director now owns 2,685 shares of the company’s stock, valued at $173,800.05. This trade represents a 66.69 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the sale, the executive vice president now directly owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by insiders.
Ryan Specialty Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More
- Five stocks we like better than Ryan Specialty
- How to Buy Cheap Stocks Step by Step
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- What Are Dividend Challengers?
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Quiet Period Expirations Explained
- Discover the 3 Best Performing Stocks That Went Public in 2024
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.